Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Vladimir Bogin"'
Autor:
Vladimir Bogin
Publikováno v:
Contemporary Clinical Trials Communications, Vol 26, Iss , Pp 100900- (2022)
It has been over 40 years since Lasagna's Law was first introduced and its main postulates are still permeating the clinical trial arena.This article attempts to identify the most pressing roadblocks in patient recruitment, categorizes them based on
Externí odkaz:
https://doaj.org/article/3809f15f44284b92a9c6ef7fffc86050
Autor:
Vladimir Bogin, MD
Publikováno v:
Contemporary Clinical Trials Communications, Vol 18, Iss , Pp 100568- (2020)
A master protocol is a unifying study construct that includes multiple subgroups and substudies, with patients having same or different diseases and that employ one or multiple drugs to treat it. Initially designed for oncology, master protocol trial
Externí odkaz:
https://doaj.org/article/30af07ef2a2c4cfa9bcc82f60fc84934
Publikováno v:
Journal of Translational Medicine, Vol 15, Iss 1, Pp 1-10 (2017)
Abstract Background Current treatments of panic disorder (PD) are limited by adverse effects, poor efficacy, and need for chronic administration. The established safety profile of subanesthetic concentrations of xenon gas, which is known to act as a
Externí odkaz:
https://doaj.org/article/4edec752aa3d405cac700115cf4e37a1
Autor:
Bin Chen, Kaizhi Lu, Qian Chen, Jiaolin Ning, Kwok Wing Joyce Lam, Zhen Yang, Wenhan Qing, Vladimir Bogin, Emma Mi, Thomas E. Ichim, Bin Yi, Daqing Ma, Hailin Zhao, Jianteng Gu
Publikováno v:
Theranostics
Diabetic foot ulcers are associated with significant morbidity and mortality, and current treatments are far from optimal. Chronic wounds in diabetes are characterised by impaired angiogenesis, leukocyte function, fibroblast proliferation, and kerati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cf15c9b4b15f5da365cb1e7a8ee83819
http://europepmc.org/articles/PMC6376177
http://europepmc.org/articles/PMC6376177
Autor:
Thomas E. Ichim, Francisco Silva, Santosh Kesari, Amit N. Patel, Samuel C. Wagner, Wei-Ping Min, Vladimir Bogin
Publikováno v:
Oncotarget
// Samuel C. Wagner 1, * , Thomas E. Ichim 1, * , Vladimir Bogin 1 , Wei-Ping Min 2 , Francisco Silva 3 , Amit N. Patel 3 , Santosh Kesari 4 1 Batu Biologics, Inc. San Diego, CA, USA 2 Department of Immunology, University of Western Ontario, London,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2ecc3423b0460859636a990dd967b47f
https://doi.org/10.18632/oncotarget.15563
https://doi.org/10.18632/oncotarget.15563
Autor:
Alexander Dobrovolsky, A. V. Malyshev, V. A. Dubynin, I. Sukhanova, Thomas E. Ichim, Daqing Ma, Vladimir Bogin, V. R. Gedzun
Publikováno v:
Journal of Translational Medicine
Journal of Translational Medicine, Vol 17, Iss 1, Pp 1-15 (2019)
Journal of Translational Medicine, Vol 17, Iss 1, Pp 1-15 (2019)
Background Xenon (Xe) is a noble gas that has been used for the last several decades as an anesthetic during surgery. Its antagonistic effect on glutamate subtype of NMDA (N-methyl-d-aspartate) receptors resulted in evaluation of this gas for treatme
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::76df5a7c1ba43d48a0b44799d484e9a5
http://europepmc.org/articles/PMC6891980
http://europepmc.org/articles/PMC6891980
Publikováno v:
The Primary Care Companion For CNS Disorders. 21
Posttraumatic stress disorder (PTSD) is a debilitating disease with limited available treatment options and for which novel effective interventions constitute a significant unmet need. This case report describes successful treatment of a patient with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5cb30441218ed8b92bba38763c6ad4db
https://doi.org/10.4088/pcc.18nr02395
https://doi.org/10.4088/pcc.18nr02395
Publikováno v:
Journal of Translational Medicine
Journal of Translational Medicine, Vol 15, Iss 1, Pp 1-10 (2017)
Journal of Translational Medicine, Vol 15, Iss 1, Pp 1-10 (2017)
Background Current treatments of panic disorder (PD) are limited by adverse effects, poor efficacy, and need for chronic administration. The established safety profile of subanesthetic concentrations of xenon gas, which is known to act as a glutamate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::705b9dd84b8501daaa389014300fb6b7
https://pubmed.ncbi.nlm.nih.gov/28610592
https://pubmed.ncbi.nlm.nih.gov/28610592
Autor:
Thomas E. Ichim, Vladimir Bogin
Publikováno v:
Regenerative Medicine ISBN: 9781447165415
In 2007, we discovered a novel subset of mesenchymal stem cells (MSCs) derived from the endometrium, termed “endometrial regenerative cells (ERC).” In comparison to other MSC types (e.g., bone marrow and adipose), ERC possess (a) more rapid proli
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::107450776f4431ba8e22f1bdfb96f53a
https://doi.org/10.1007/978-1-4471-6542-2_4
https://doi.org/10.1007/978-1-4471-6542-2_4
Autor:
Vladimir Bogin, Olga L. Bockeria, Leo A. Bockeria, Amit N. Patel, Erik J. Woods, Thomas E. Ichim, Amalia A Brown, Bagrat Alekyan, Tatyana Le
Publikováno v:
Journal of Translational Medicine
Heart failure is one of the key causes of morbidity and mortality world-wide. The recent findings that regeneration is possible in the heart have made stem cell therapeutics the Holy Grail of modern cardiovascular medicine. The success of cardiac reg
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f4bb6cae605ed641e61a80ad73337344
https://doi.org/10.1186/1479-5876-11-56
https://doi.org/10.1186/1479-5876-11-56